Testing effectiveness (Phase 2)Study completedNCT01780454What this trial is testingRenal Allograft Tolerance Through Mixed ChimerismWho this might be right forEnd Stage Renal Disease Massachusetts General Hospital 2
Testing effectiveness (Phase 2)WithdrawnNCT03606746What this trial is testingCellular Immunotherapy for Immune Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kidney TransplantsWho this might be right forKidney Transplant Rejection Medeor Therapeutics, Inc.
Testing effectiveness (Phase 2)Study completedNCT00004143What this trial is testingAllogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure SyndromesWho this might be right forSickle Cell AnemiaSevere Aplastic AnemiaParoxysmal Nocturnal Hemoglobinuria (PNH)+1 more David Rizzieri, MD 2
Testing effectiveness (Phase 2)Study completedNCT00176865What this trial is testingStem Cell Transplant for Immunologic or Histiocytic DisordersWho this might be right forHemophagocytic LymphohistiocytosisX-Linked Lymphoproliferative DisordersChediak-Higashi Syndrome+3 more Masonic Cancer Center, University of Minnesota 19
Testing effectiveness (Phase 2)Ended earlyNCT02029638What this trial is testingBMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft ToleranceWho this might be right forKidney Transplantation National Institute of Allergy and Infectious Diseases (NIAID) 4
Early research (Phase 1)UnknownNCT01793025What this trial is testingMismatched Donor Cells to Treat Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Maisonneuve-Rosemont Hospital 12
Early research (Phase 1)Study completedNCT00008450What this trial is testingTotal-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow TransplantWho this might be right forAdenosine Deaminase DeficiencyAutosomal Recessive DisorderImmune System Disorder+4 more Fred Hutchinson Cancer Center 6
Not applicableStudy completedNCT00112593What this trial is testingFludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+176 more Fred Hutchinson Cancer Center 5
Not applicableUnknownNCT03101423What this trial is testingMonitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategies for the Reduction of ChimerismWho this might be right forBeta Thalassemia Major First Affiliated Hospital of Guangxi Medical University 30
Testing effectiveness (Phase 2)WithdrawnNCT01419704What this trial is testingPhase I/II Pilot Study of Mixed Chimerism to Treat HemoglobinopathiesWho this might be right forAnemia, Sickle CellComplex and Transfusion-dependent HemoglobinopathiesThalassemia+4 more Talaris Therapeutics Inc.
Testing effectiveness (Phase 2)Study completedNCT00004485What this trial is testingBone Marrow Transplantation in Treating Children With Sickle Cell DiseaseWho this might be right forSickle Cell Anemia Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT03707262What this trial is testingStudy of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister DonorWho this might be right forRenal Transplant RejectionToleranceKidney Transplant Jeffrey Veale, MD 15
Early research (Phase 1)UnknownNCT00531635What this trial is testingInduction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate MofetilWho this might be right forPost Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil King Faisal Specialist Hospital & Research Center 350
Not applicableStudy completedNCT00480506What this trial is testingMonitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia MajorWho this might be right forThalassemia Major Dana-Farber Cancer Institute 40
Early research (Phase 1)Ended earlyNCT02370888What this trial is testingLenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual DiseaseWho this might be right forLeukemia, MyeloidMyelodysplastic Syndromes University of Florida 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT00408447What this trial is testingStem Cell Transplant in Sickle Cell Disease and ThalassemiaWho this might be right forSickle Cell DiseaseBeta Thalassemia Columbia University 53
Not applicableStudy completedNCT05249452What this trial is testingAdding Azathioprine/Hydroxyurea Preconditioning to Alemtuzumab/TBI to Reduce Risk of Graft Failure in MSD HSCT in Adult SCD PatientsWho this might be right forSickle Cell Disease Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 20
Not applicableUnknownNCT04944511What this trial is testingPD-1 Antibody Improve Mixed ChimerismWho this might be right forPD-1 AntibodyMixed Chimerism Beijing Friendship Hospital 20
Early research (Phase 1)Study completedNCT00062621What this trial is testingCombined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney FailureWho this might be right forKidney Failure, ChronicMultiple Myeloma National Institute of Allergy and Infectious Diseases (NIAID) 5
Testing effectiveness (Phase 2)WithdrawnNCT03982992What this trial is testingAllogeneic Donor Lymphocyte Infusions Combined With BlinatumomabWho this might be right forB Cell Precursor Acute Lymphoblastic Leukemia With Mixed Chimerism or Minimal Residual Disease After Allogeneic Stem Cell TransplantationB-Cell Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia+2 more Ludwig-Maximilians - University of Munich